NEW YORK (360Dx) – Bio-Rad Laboratories said Thursday that the US Food and Drug Administration has cleared its BioPlex 2200 ToRC IgM Assay, an automated and multiplexed panel for the detection of IgM class antibodies to Toxoplasma gondii, rubella, and cytomegalovirus (CMV).

Toxoplasma gondii, rubella, and CMV are pathogens commonly associated with congenital diseases and therefore are tested during the first trimester of pregnancy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.